Amedeo's Top 20

Amedeo Smart

Independent Medical Education

09 April 2018

Multidisciplinary Journal Club

  1. Reignier J, Boisrame-Helms J, Brisard L, Lascarrou JB, et al.
    Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2).
    Lancet 2017.

  1. Thompson AJ, Baranzini SE, Geurts J, Hemmer B, et al.
    Multiple sclerosis.
    Lancet 2018.

  2. Riddell J 4th, Amico KR, Mayer KH.
    HIV Preexposure Prophylaxis: A Review.
    JAMA 2018;319:1261-1268.

  3. Kappos L, Bar-Or A, Cree BAC, Fox RJ, et al.
    Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
    Lancet 2018.

  4. Jongen-Lavrencic M, Grob T, Hanekamp D, Kavelaars FG, et al.
    Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
    N Engl J Med 2018;378:1189-1199.

  1. Tam CS, Anderson MA, Pott C, Agarwal R, et al.
    Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma.
    N Engl J Med 2018;378:1211-1223.

  2. Grothey A, Sobrero AF, Shields AF, Yoshino T, et al.
    Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
    N Engl J Med 2018;378:1177-1188.

  3. Taher AT, Weatherall DJ, Cappellini MD.
    Lancet 2018;391:155-167.

  4. Foster NE, Anema JR, Cherkin D, Chou R, et al.
    Prevention and treatment of low back pain: evidence, challenges, and promising directions.
    Lancet 2018.

  5. Cheson BD, Chua N, Mayer J, Dueck G, et al.
    Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study.
    J Clin Oncol 2018.

  1. Takeuchi H, Fathi A, Thiyanavadivel S, Agid O, et al.
    Can Aripiprazole Worsen Psychosis in Schizophrenia? A Meta-Analysis of Double-Blind, Randomized, Controlled Trials.
    J Clin Psychiatry 2018;79.

  2. .
    European evidence-based guidelines on pancreatic cystic neoplasms.
    Gut 2018.

  3. Armand P, Engert A, Younes A, Fanale M, et al.
    Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.
    J Clin Oncol 2018.

  4. El Bcheraoui C, Mokdad AH, Dwyer-Lindgren L, Bertozzi-Villa A, et al.
    Trends and Patterns of Differences in Infectious Disease Mortality Among US Counties, 1980-2014.
    JAMA 2018;319:1248-1260.

  5. Yamaguchi M, Suzuki R, Oguchi M.
    Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
    Blood 2018.

  1. Kitahara CM, Farkas DKR, Jorgensen JOL, Cronin-Fenton D, et al.
    Benign Thyroid Diseases and Risk of Thyroid Cancer: A Nationwide Cohort Study.
    J Clin Endocrinol Metab 2018.

  2. Zhang DL, Wu J, Shah BN, Greutelaers KC, et al.
    Erythrocytic ferroportin reduces intracellular iron accumulation, hemolysis, and malaria risk.
    Science 2018;359:1520-1523.

  3. Ensminger S, Fujita B, Bauer T, Mollmann H, et al.
    Rapid Deployment Versus Conventional Bioprosthetic Valve Replacement for Aortic Stenosis.
    J Am Coll Cardiol 2018;71:1417-1428.

  4. Gemenetzis G, Groot VP, Blair AB, Laheru DA, et al.
    Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection.
    Ann Surg 2018.

  5. Freeman SD, Hills RK, Virgo P, Khan N, et al.
    Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations.
    J Clin Oncol 2018.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016